Assessment of Empathetic Process by Scanpath Study of an Artwork
NCT ID: NCT04665622
Last Updated: 2022-03-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
70 participants
INTERVENTIONAL
2016-04-01
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Eye Gaze Strategies During Facial Emotion Recognition in Neurodegenerative Diseases: Links With Neuropsychiatric Disorders (EYE-ToM Study)
NCT04748263
Quantitative Evaluation of Apathy Close to Real Life Situation by Means of a Multimodal Sensor System Integrated.
NCT02496312
Investigating the Role of the Premotor Cortex in Higher Cognitive Functions
NCT00842413
Vestibular and Multisensory Influence on Bodily and Spatial Representations. Behavioral and Electrophysiological Investigations in Vestibular-defective Patients and Healthy Volunteers
NCT01900457
Vestibular and Multisensory Influence on Bodily and Spatial Representations
NCT02072460
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Fronto-temporal Dementia
10 subjects
Eye-Tracking / Neuropsychological evaluations
Use of Eye-Tracking / Neuropsychological évaluations in 4 groups
Alzheimer's Dementia
20 subjects
Eye-Tracking / Neuropsychological evaluations
Use of Eye-Tracking / Neuropsychological évaluations in 4 groups
Parkinson's Disease
20 subjects
Eye-Tracking / Neuropsychological evaluations
Use of Eye-Tracking / Neuropsychological évaluations in 4 groups
Healthy volunteers
20 subjects
Eye-Tracking / Neuropsychological evaluations
Use of Eye-Tracking / Neuropsychological évaluations in 4 groups
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Eye-Tracking / Neuropsychological evaluations
Use of Eye-Tracking / Neuropsychological évaluations in 4 groups
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 60 years old and above.
* Sufficient written and oral expression in French.
* Benefit from French or Monaco Social security.
* Written informed consent signed by the patient.
* For the control group: voluntary subjects, without cognitive impairment.
* For the FTD / AD / PD groups: patients diagnosed with one of these diseases, and volunteers to participate in the study.
Exclusion Criteria
* Ophthalmological problems preventing a video-oculography examination.
* Oculomotor disorders such as "fixation disorders" or "ocular tracking disorders".
* History of stroke.
* Cognitive disorders of the type: visual agnosia, visuo-spatial disorder, visuo-perceptual disorder or aphasia.
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Association de Recherche Bibliographique pour les Neurosciences
OTHER
Centre Hospitalier Princesse Grace
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Princesse Grace
Monaco, , Monaco
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EYE-EMPATH
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.